These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 33275687)

  • 41. Expected individual benefit of prophylactic platelet transfusions in hemato-oncology patients based on bleeding risks.
    Cornelissen LL; Caram-Deelder C; Fustolo-Gunnink SF; Groenwold RHH; Stanworth SJ; Zwaginga JJ; van der Bom JG
    Transfusion; 2021 Sep; 61(9):2578-2587. PubMed ID: 34263930
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Compliance with prophylactic platelet transfusion trigger in haematological patients.
    Eikenboom JC; van Wordragen R; Brand A
    Transfus Med; 2005 Feb; 15(1):45-8. PubMed ID: 15713128
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A prospective randomized trial of HLA-matched versus mismatched single-donor platelet transfusions in cancer patients.
    Messerschmidt GL; Makuch R; Appelbaum F; Ungerleider RS; Abrams R; O'Donnell J; Holohan TV; Fontana J; Wright D; Anagnou NP
    Cancer; 1988 Aug; 62(4):795-801. PubMed ID: 3293762
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prophylactic platelet transfusions from healthy apheresis platelet donors undergoing treatment with thrombopoietin.
    Goodnough LT; Kuter DJ; McCullough J; Slichter SJ; DiPersio J; Romo J; Peterson R; Smith KJ; Raife T; Tomita D; Armstrong S
    Blood; 2001 Sep; 98(5):1346-51. PubMed ID: 11520781
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Factors affecting posttransfusion platelet increments, platelet refractoriness, and platelet transfusion intervals in thrombocytopenic patients.
    Slichter SJ; Davis K; Enright H; Braine H; Gernsheimer T; Kao KJ; Kickler T; Lee E; McFarland J; McCullough J; Rodey G; Schiffer CA; Woodson R
    Blood; 2005 May; 105(10):4106-14. PubMed ID: 15692069
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Thrombocytopenia and hemorrhagic risk in cancer patients.
    Avvisati G; Tirindelli MC; Annibali O
    Crit Rev Oncol Hematol; 2003 Oct; 48(Suppl):S13-6. PubMed ID: 14563516
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prophylactic versus therapeutic platelet transfusion practices in hematology and/or oncology patients.
    Pisciotto PT; Benson K; Hume H; Glassman AB; Oberman H; Popovsky M; Hines D; Anderson K
    Transfusion; 1995 Jun; 35(6):498-502. PubMed ID: 7770901
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Randomized Trial of Platelet-Transfusion Thresholds in Neonates.
    Curley A; Stanworth SJ; Willoughby K; Fustolo-Gunnink SF; Venkatesh V; Hudson C; Deary A; Hodge R; Hopkins V; Lopez Santamaria B; Mora A; Llewelyn C; D'Amore A; Khan R; Onland W; Lopriore E; Fijnvandraat K; New H; Clarke P; Watts T;
    N Engl J Med; 2019 Jan; 380(3):242-251. PubMed ID: 30387697
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Platelet Transfusion Practices in Critically Ill Children.
    Nellis ME; Karam O; Mauer E; Cushing MM; Davis PJ; Steiner ME; Tucci M; Stanworth SJ; Spinella PC;
    Crit Care Med; 2018 Aug; 46(8):1309-1317. PubMed ID: 29727368
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Peridischarge prophylactic platelet transfusions after stem cell transplant: is a tranfusion trigger needed?
    Meehan KR; Sharma P; McKenna DR; Dunbar NM
    Transfusion; 2016 May; 56(5):1082-7. PubMed ID: 26867956
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Platelet transfusions: treatment options for hemorrhage secondary to thrombocytopenia.
    Hux BD; Martin LG
    J Vet Emerg Crit Care (San Antonio); 2012 Feb; 22(1):73-80. PubMed ID: 23016744
    [TBL] [Abstract][Full Text] [Related]  

  • 52. How low can you go: What is the safe threshold for platelet transfusions in patients with hematologic malignancy in sub-Saharan Africa.
    Ddungu H; Krantz EM; Kajja I; Naluzze S; Nabbanja H; Nalubwama F; Phipps W; Orem J; Kiwanuka N; Wald A
    PLoS One; 2019; 14(2):e0211648. PubMed ID: 30726290
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Do basic laboratory tests or clinical observations predict bleeding in thrombocytopenic oncology patients? A reevaluation of prophylactic platelet transfusions.
    Friedmann AM; Sengul H; Lehmann H; Schwartz C; Goodman S
    Transfus Med Rev; 2002 Jan; 16(1):34-45. PubMed ID: 11788928
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Platelets Structure, Function and Modulator Capacity in Replacement Therapy.
    Moutinho B; Pinto B; Cardoso R; Botelho MC
    Cardiovasc Hematol Disord Drug Targets; 2017; 17(3):180-184. PubMed ID: 29283062
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The Bleeding Risk Index: a clinical prediction rule to guide the prophylactic use of platelet transfusions in patients with lymphoma or solid tumors.
    Elting LS; Martin CG; Kurtin DJ; Cantor SB; Rubenstein EB; Rodriguez S; Kanesan K; Vadhan-Raj S; Benjamin RS
    Cancer; 2002 Jun; 94(12):3252-62. PubMed ID: 12115358
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Thrombocytopenia, bleeding, and use of platelet transfusions in sick neonates.
    Stanworth SJ
    Hematology Am Soc Hematol Educ Program; 2012; 2012():512-6. PubMed ID: 23233627
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Acute bleeding complications in patients after hematopoietic stem cell transplantation with prophylactic platelet transfusion triggers of 10 x 10(9) and 20 x 10(9) per L.
    Nevo S; Fuller AK; Hartley E; Borinsky ME; Vogelsang GB
    Transfusion; 2007 May; 47(5):801-12. PubMed ID: 17465944
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Lack of efficacy of prophylactic platelet transfusion for severe thrombocytopenia in adults with acute uncomplicated dengue infection.
    Lye DC; Lee VJ; Sun Y; Leo YS
    Clin Infect Dis; 2009 May; 48(9):1262-5. PubMed ID: 19292665
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Safety of lumbar punctures in patients with thrombocytopenia.
    Ning S; Kerbel B; Callum J; Lin Y
    Vox Sang; 2016 May; 110(4):393-400. PubMed ID: 26831046
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Optimal dosing and triggers for prophylactic use of platelet transfusions.
    Rinder HM; Arbini AA; Snyder EL
    Curr Opin Hematol; 1999 Nov; 6(6):437-41. PubMed ID: 10546800
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.